Rory B. Riggs

Insider Reports History

Location
Ridgefield, NJ
Signature
/s/ Rory B. Riggs
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rory B. Riggs:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cibus, Inc. Director, 10%+ Owner Pre-Funded Warrant 4,000,000 $9,999,600 $2.50 21 Jan 2025 Direct
Royalty Pharma plc Director Class A Ordinary Shares 320,099 $8,817,959 $27.55 20 Feb 2024 Direct
Royalty Pharma plc Director Class A Ordinary Shares 85,187 $2,346,697 $27.55 20 Feb 2024 By New Ventures III LLC
FIBROGEN INC Director Common Stock 605,713 $460,342 $0.7600 26 May 2021 Indirect
Royalty Pharma plc Director Class A Ordinary Shares 15,000 $413,214 $27.55 20 Feb 2024 By Spouse
FIBROGEN INC Director Common Stock 395,750 $300,770 $0.7600 26 May 2021 Direct
Cibus, Inc. Director, 10%+ Owner Class A Common Stock 14,583,307 $145,833 $0.0100 09 Jun 2025 Direct
Cibus, Inc. Director, 10%+ Owner Class A Common Stock 23,807 $54,994 $2.31 09 Jun 2025 Indirect
Cibus, Inc. Director, 10%+ Owner Class A Common Stock 20,974 $48,449 $2.31 09 Jun 2025 By Spouse
Cibus, Inc. Director, 10%+ Owner Cibus Common Unit 0 $0 $5.30 31 Dec 2024 Direct
Intra-Cellular Therapies, Inc. Director Common Stock 0 $0 $132.00 02 Apr 2025 Direct
Intra-Cellular Therapies, Inc. Director Restricted Stock Units 0 $0 $132.00 02 Apr 2025 Direct
Cibus, Inc. Director, 10%+ Owner Common Warrant 4,000,000 21 Jan 2025 Direct
Royalty Pharma plc Director LP interests in RPI US Partners 2019, LP 270,000 20 Feb 2024 Direct
Cibus, Inc. Director, 10%+ Owner Stock Option (Right-to-Buy) 39,301 22 May 2025 Direct
FIBROGEN INC Director Stock Option (Right to Buy) 7,800 26 May 2021 Direct
Cibus, Inc. Director, 10%+ Owner Class B Common Stock 0 31 Dec 2024 Direct
Cibus, Inc. Director, 10%+ Owner Pre-Funded Warrant (right to buy) 0 09 Jun 2025 Direct
Intra-Cellular Therapies, Inc. Director Stock Option (right to buy) 0 02 Apr 2025 Direct

Insider Reports Filed by Rory B. Riggs

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CBUS Cibus, Inc. 09 Jun 2025 4 +$900 4 Director, 10%+ Owner 11 Jun 2025, 17:11
CBUS Cibus, Inc. 05 Jun 2025 1 +$10,000,000 4 Director, 10%+ Owner 10 Jun 2025, 16:15
CBUS Cibus, Inc. 22 May 2025 1 $0 4 Director 27 May 2025, 15:07
ITCI Intra-Cellular Therapies, Inc. 02 Apr 2025 9 -$17,359,584 4 Director 02 Apr 2025, 17:47
CBUS Cibus, Inc. 21 Jan 2025 2 +$9,999,600 4 Chief Executive Officer, Director, 10%+ Owner 23 Jan 2025, 16:19
CBUS Cibus, Inc. 31 Dec 2024 3 $0 4 Chief Executive Officer, Director, 10%+ Owner 10 Jan 2025, 09:51
ITCI Intra-Cellular Therapies, Inc. 31 Dec 2024 1 +$17,957 4 Director 03 Jan 2025, 18:01
ITCI Intra-Cellular Therapies, Inc. 30 Sep 2024 1 +$18,000 4 Director 02 Oct 2024, 18:01
CBUS Cibus, Inc. 18 Sep 2024 1 +$1,000,000 4 Chief Executive Officer, Director, 10%+ Owner 20 Sep 2024, 17:48
ITCI Intra-Cellular Therapies, Inc. 28 Jun 2024 1 +$17,944 4 Director 02 Jul 2024, 20:00
ITCI Intra-Cellular Therapies, Inc. 23 Jun 2024 5 +$6.66 4 Director 25 Jun 2024, 18:04
ITCI Intra-Cellular Therapies, Inc. 14 Jun 2024 2 $0 4 Director 18 Jun 2024, 18:02
CBUS Cibus, Inc. 11 Jun 2024 2 +$1,000,008 4 Chief Executive Officer, Director, 10%+ Owner 14 Jun 2024, 06:53
ITCI Intra-Cellular Therapies, Inc. 31 Mar 2024 1 +$17,992 4 Director 02 Apr 2024, 16:15
ITCI Intra-Cellular Therapies, Inc. 20 Mar 2024 2 +$371,200 4 Director 22 Mar 2024, 16:12
RPRX Royalty Pharma plc 20 Feb 2024 2 $0 4 Director 22 Feb 2024, 19:23
RPRX Royalty Pharma plc 02 Jan 2024 3 -$13,222,862 4 Director 04 Jan 2024, 17:16
ITCI Intra-Cellular Therapies, Inc. 31 Dec 2023 1 +$17,977 4 Director 03 Jan 2024, 18:46
CBUS Cibus, Inc. 29 Dec 2023 5 $0 4 Chief Executive Officer, Director, 10%+ Owner 03 Jan 2024, 19:08
CBUS Cibus, Inc. 12 Dec 2023 3 +$5,999,492 4 Chief Executive Officer, Director, 10%+ Owner 14 Dec 2023, 17:10
RPRX Royalty Pharma plc 13 Nov 2023 2 $0 4 Director 14 Nov 2023, 17:17
ITCI Intra-Cellular Therapies, Inc. 30 Sep 2023 1 +$17,971 4 Director 02 Oct 2023, 17:29
RPRX Royalty Pharma plc 08 Aug 2023 1 $0 4 Director 08 Aug 2023, 17:39
ITCI Intra-Cellular Therapies, Inc. 30 Jun 2023 1 +$17,666 4 Director 05 Jul 2023, 16:30
ITCI Intra-Cellular Therapies, Inc. 23 Jun 2023 2 $0 4 Director 27 Jun 2023, 17:11
RPRX Royalty Pharma plc 23 Jun 2023 1 $0 4 Director 26 Jun 2023, 16:14
CBUS Cibus, Inc. 31 May 2023 0 $0 4/A Chief Executive Officer, Director, 10%+ Owner 15 Jun 2023, 16:05
CBUS Cibus, Inc. 31 May 2023 0 $0 3 Chief Executive Officer, Director 02 Jun 2023, 07:00
RPRX Royalty Pharma plc 22 May 2023 1 -$57,435,000 4 Director 22 May 2023, 20:36
RPRX Royalty Pharma plc 09 May 2023 2 $0 4 Director 12 May 2023, 18:43
ITCI Intra-Cellular Therapies, Inc. 31 Mar 2023 1 +$16,949 4 Director 04 Apr 2023, 17:01
RPRX Royalty Pharma plc 29 Mar 2023 2 -$5,081,111 4 Director 30 Mar 2023, 17:53
RPRX Royalty Pharma plc 17 Feb 2023 2 $0 4 Director 17 Feb 2023, 15:59
ITCI Intra-Cellular Therapies, Inc. 30 Dec 2022 1 +$16,987 4 Director 03 Jan 2023, 15:18
RPRX Royalty Pharma plc 09 Dec 2022 2 -$2,520,623 4 Director 13 Dec 2022, 17:20
RPRX Royalty Pharma plc 17 Nov 2022 1 -$5,079,924 4 Director 21 Nov 2022, 17:12
ITCI Intra-Cellular Therapies, Inc. 30 Sep 2022 1 +$16,983 4 Director 04 Oct 2022, 16:11
RPRX Royalty Pharma plc 14 Sep 2022 2 -$4,230,387 4 Director 15 Sep 2022, 19:56
RPRX Royalty Pharma plc 09 Aug 2022 1 -$1,967,823 4 Director 11 Aug 2022, 17:07
ITCI Intra-Cellular Therapies, Inc. 30 Jun 2022 1 +$16,496 4 Director 05 Jul 2022, 16:06
RPRX Royalty Pharma plc 29 Jun 2022 1 -$1,265,238 4 Director 29 Jun 2022, 18:02
ITCI Intra-Cellular Therapies, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 17:08
RPRX Royalty Pharma plc 19 May 2022 2 -$5,913,306 4 Director 23 May 2022, 16:55
ITCI Intra-Cellular Therapies, Inc. 31 Mar 2022 1 +$15,726 4 Director 04 Apr 2022, 16:08
RPRX Royalty Pharma plc 29 Mar 2022 1 -$2,315,322 4 Director 30 Mar 2022, 18:46
RPRX Royalty Pharma plc 17 Mar 2022 10 -$6,667,521 4 Director 21 Mar 2022, 18:20
ITCI Intra-Cellular Therapies, Inc. 16 Mar 2022 6 -$13,623,979 4 Director 18 Mar 2022, 20:12
ITCI Intra-Cellular Therapies, Inc. 31 Dec 2021 1 +$15,702 4 Director 04 Jan 2022, 20:50
RPRX Royalty Pharma plc 28 Dec 2021 9 -$7,400,767 4 Director 30 Dec 2021, 17:07
RPRX Royalty Pharma plc 16 Nov 2021 10 -$9,076,492 4 Director 18 Nov 2021, 18:15
ITCI Intra-Cellular Therapies, Inc. 30 Sep 2021 1 +$15,732 4 Director 04 Oct 2021, 16:24
RPRX Royalty Pharma plc 28 Sep 2021 12 -$4,688,288 4 Director 30 Sep 2021, 15:56
ITCI Intra-Cellular Therapies, Inc. 30 Jun 2021 1 +$15,716 4 Director 02 Jul 2021, 16:52
RPRX Royalty Pharma plc 25 Jun 2021 5 -$55,370,134 4 Director 29 Jun 2021, 20:31
ITCI Intra-Cellular Therapies, Inc. 21 Jun 2021 1 $0 4 Director 22 Jun 2021, 16:21
RPRX Royalty Pharma plc 07 Jun 2021 1 +$12,385,399 4 Director 08 Jun 2021, 20:13
ITCI Intra-Cellular Therapies, Inc. 27 May 2021 2 $0 4 Director 04 Jun 2021, 16:05
FGEN FIBROGEN INC 26 May 2021 2 $0 4 Director 28 May 2021, 19:08
RPRX Royalty Pharma plc 07 May 2021 4 $0 4 Director 11 May 2021, 21:00
ITCI Intra-Cellular Therapies, Inc. 18 Jun 2019 2 $0 4 Director 15 Oct 2024, 18:00